Baker Bros. Capital (GP), LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Bros. Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Bros. Capital (GP), LLC. Baker Bros. Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Latest Insider Trading Transactions of Baker Bros. Capital (GP), LLC
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, HRTX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO, VPHM
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 11 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.94 | 247 | 2,703 | 281,862 | 281.6 K to 281.9 K (+0.09 %) |
| Jan 08 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.00 | 66 | 660 | 281,615 | 281.5 K to 281.6 K (+0.02 %) |
| Jan 08 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.89 | 1,252 | 13,639 | 281,549 | 280.3 K to 281.5 K (+0.45 %) |
| Jan 08 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.48 | 579 | 5,490 | 280,297 | 279.7 K to 280.3 K (+0.21 %) |
| Jan 08 2008 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.47 | 815 | 7,715 | 279,718 | 278.9 K to 279.7 K (+0.29 %) |
| Jan 14 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 13.00 | 42 | 546 | 89,458 | 89.5 K to 89.5 K (-0.05 %) |
| Jan 09 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 13.00 | 212 | 2,756 | 89,500 | 89.7 K to 89.5 K (-0.24 %) |
| Jan 09 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 13.00 | 5 | 65 | 89,712 | 89.7 K to 89.7 K (-0.01 %) |
| Jan 09 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 13.00 | 5 | 65 | 89,717 | 89.7 K to 89.7 K (-0.01 %) |
| Jan 04 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 13.14 | 1,031 | 13,550 | 89,722 | 90.8 K to 89.7 K (-1.14 %) |
| Jan 04 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 13.29 | 990 | 13,159 | 90,753 | 91.7 K to 90.8 K (-1.08 %) |
| Jan 04 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 12.94 | 2,947 | 38,144 | 91,743 | 94.7 K to 91.7 K (-3.11 %) |
| Feb 27 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.00 | 91 | 546 | 191,820 | 191.7 K to 191.8 K (+0.05 %) |
| Feb 21 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.20 | 64 | 397 | 191,729 | 191.7 K to 191.7 K (+0.03 %) |
| Feb 21 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.90 | 68 | 401 | 191,665 | 191.6 K to 191.7 K (+0.04 %) |
| Feb 21 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.50 | 104 | 676 | 191,597 | 191.5 K to 191.6 K (+0.05 %) |
| Feb 21 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.75 | 103 | 696 | 191,493 | 191.4 K to 191.5 K (+0.05 %) |
| Jan 23 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.95 | 53 | 368 | 191,390 | 191.3 K to 191.4 K (+0.03 %) |
| Jan 23 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.92 | 1 | 7 | 191,337 | 191.3 K to 191.3 K (0.00 %) |
| Jan 23 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.15 | 11 | 79 | 191,336 | 191.3 K to 191.3 K (+0.01 %) |
| Jan 23 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.22 | 12 | 87 | 191,325 | 191.3 K to 191.3 K (+0.01 %) |
| Jan 17 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.50 | 47 | 353 | 191,313 | 191.3 K to 191.3 K (+0.02 %) |
| Jan 14 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.41 | 245 | 1,817 | 191,266 | 191 K to 191.3 K (+0.13 %) |
| Jan 14 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.47 | 103 | 770 | 191,021 | 190.9 K to 191 K (+0.05 %) |
| Jan 14 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.47 | 218 | 1,628 | 190,918 | 190.7 K to 190.9 K (+0.11 %) |
| Jan 09 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.96 | 117 | 814 | 190,700 | 190.6 K to 190.7 K (+0.06 %) |
| Jan 09 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.21 | 376 | 2,712 | 190,583 | 190.2 K to 190.6 K (+0.20 %) |
| Jan 09 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.85 | 188 | 1,288 | 190,207 | 190 K to 190.2 K (+0.10 %) |
| Jan 09 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.37 | 2 | 13 | 190,019 | 190 K to 190 K (0.00 %) |
| Nov 09 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.63 | 532 | 4,060 | 143,496 | 143 K to 143.5 K (+0.37 %) |
| Nov 09 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.43 | 934 | 6,943 | 142,964 | 142 K to 143 K (+0.66 %) |
| Nov 09 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.27 | 747 | 5,434 | 142,030 | 141.3 K to 142 K (+0.53 %) |
| Dec 19 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.61 | 243 | 2,578 | 278,903 | 278.7 K to 278.9 K (+0.09 %) |
| Dec 19 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.58 | 147 | 1,556 | 278,660 | 278.5 K to 278.7 K (+0.05 %) |
| Dec 19 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.60 | 258 | 2,734 | 278,513 | 278.3 K to 278.5 K (+0.09 %) |
| Dec 12 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 10.38 | 465 | 4,829 | 278,255 | 277.8 K to 278.3 K (+0.17 %) |
| Dec 12 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.85 | 182 | 1,793 | 277,790 | 277.6 K to 277.8 K (+0.07 %) |
| Dec 12 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.87 | 240 | 2,369 | 277,608 | 277.4 K to 277.6 K (+0.09 %) |
| Dec 12 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 9.54 | 296 | 2,825 | 277,368 | 277.1 K to 277.4 K (+0.11 %) |
| Dec 06 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.98 | 153 | 1,374 | 277,072 | 276.9 K to 277.1 K (+0.06 %) |
| Nov 28 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.40 | 342 | 2,872 | 276,661 | 276.3 K to 276.7 K (+0.12 %) |
| Nov 28 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.00 | 530 | 4,239 | 276,319 | 275.8 K to 276.3 K (+0.19 %) |
| Nov 28 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 7.94 | 230 | 1,826 | 275,789 | 275.6 K to 275.8 K (+0.08 %) |
| Dec 03 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.96 | 64 | 574 | 276,919 | 276.9 K to 276.9 K (+0.02 %) |
| Dec 03 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.59 | 147 | 1,263 | 276,855 | 276.7 K to 276.9 K (+0.05 %) |
| Dec 03 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.58 | 47 | 403 | 276,708 | 276.7 K to 276.7 K (+0.02 %) |
| Nov 21 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.12 | 150 | 1,218 | 275,559 | 275.4 K to 275.6 K (+0.05 %) |
| Nov 21 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.10 | 210 | 1,701 | 275,409 | 275.2 K to 275.4 K (+0.08 %) |
| Nov 21 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.22 | 387 | 3,182 | 275,199 | 274.8 K to 275.2 K (+0.14 %) |
| Nov 16 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.30 | 274 | 2,275 | 274,812 | 274.5 K to 274.8 K (+0.10 %) |
| Nov 16 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.62 | 290 | 2,501 | 274,538 | 274.2 K to 274.5 K (+0.11 %) |
| Nov 16 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.53 | 335 | 2,857 | 274,248 | 273.9 K to 274.2 K (+0.12 %) |
| Nov 16 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.54 | 5 | 43 | 273,913 | 273.9 K to 273.9 K (0.00 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.25 | 234 | 1,931 | 273,908 | 273.7 K to 273.9 K (+0.09 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.26 | 53 | 438 | 273,674 | 273.6 K to 273.7 K (+0.02 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.22 | 39 | 321 | 273,621 | 273.6 K to 273.6 K (+0.01 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.30 | 63 | 523 | 273,582 | 273.5 K to 273.6 K (+0.02 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.00 | 30 | 240 | 273,519 | 273.5 K to 273.5 K (+0.01 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.23 | 57 | 469 | 273,489 | 273.4 K to 273.5 K (+0.02 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.20 | 462 | 3,789 | 273,432 | 273 K to 273.4 K (+0.17 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 8.30 | 377 | 3,129 | 272,970 | 272.6 K to 273 K (+0.14 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 7.70 | 532 | 4,098 | 272,593 | 272.1 K to 272.6 K (+0.20 %) |
| Nov 13 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 7.90 | 10 | 79 | 272,061 | 272.1 K to 272.1 K (0.00 %) |
| Dec 12 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 12.25 | 5 | 61 | 94,691 | 94.7 K to 94.7 K (-0.01 %) |
| Dec 12 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 12.25 | 265 | 3,247 | 94,696 | 95 K to 94.7 K (-0.28 %) |
| Dec 12 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 12.36 | 602 | 7,443 | 94,961 | 95.6 K to 95 K (-0.63 %) |
| Dec 07 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 12.25 | 778 | 9,534 | 95,563 | 96.3 K to 95.6 K (-0.81 %) |
| Dec 07 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 12.35 | 2,415 | 29,833 | 96,341 | 98.8 K to 96.3 K (-2.45 %) |
| Dec 07 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 12.28 | 1,184 | 14,544 | 98,756 | 99.9 K to 98.8 K (-1.18 %) |
| Nov 21 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 11.80 | 134 | 1,581 | 105,380 | 105.5 K to 105.4 K (-0.13 %) |
| Nov 15 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 11.77 | 2,532 | 29,814 | 105,514 | 108 K to 105.5 K (-2.34 %) |
| Nov 15 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 12.05 | 542 | 6,532 | 108,046 | 108.6 K to 108 K (-0.50 %) |
| Nov 15 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 12.02 | 765 | 9,196 | 108,588 | 109.4 K to 108.6 K (-0.70 %) |
| Nov 08 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 12.72 | 994 | 12,645 | 109,353 | 110.3 K to 109.4 K (-0.90 %) |
| Nov 08 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 12.66 | 4,674 | 59,164 | 110,347 | 115 K to 110.3 K (-4.06 %) |
| Nov 08 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 12.14 | 5,892 | 71,529 | 115,021 | 120.9 K to 115 K (-4.87 %) |
| Nov 05 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 12.05 | 755 | 9,100 | 120,913 | 121.7 K to 120.9 K (-0.62 %) |
| Nov 05 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 11.88 | 1,951 | 23,172 | 121,668 | 123.6 K to 121.7 K (-1.58 %) |
| Nov 05 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 11.50 | 1,555 | 17,884 | 123,619 | 125.2 K to 123.6 K (-1.24 %) |
| Oct 31 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 11.70 | 2,337 | 27,332 | 125,174 | 127.5 K to 125.2 K (-1.83 %) |
| Oct 31 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 12.03 | 3,099 | 37,277 | 127,511 | 130.6 K to 127.5 K (-2.37 %) |
| Oct 31 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 12.47 | 3,317 | 41,353 | 130,610 | 133.9 K to 130.6 K (-2.48 %) |
| Dec 21 2007 | IBPI | Ardea Biosciences, ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 13.25 | 2,059 | 27,282 | 135,746 | 133.7 K to 135.7 K (+1.54 %) |
| Jul 11 2007 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Option Exercise | C | 0.00 | 46,605 | 0 | 0 | |
| Jul 11 2007 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | C | 0.00 | 466,050 | 0 | 471,007 | 5 K to 471 K (+9,401.86 %) |
| Aug 03 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 4.83 | 430 | 2,075 | 272,051 | 271.6 K to 272.1 K (+0.16 %) |
| Aug 03 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 4.99 | 117 | 584 | 271,621 | 271.5 K to 271.6 K (+0.04 %) |
| Aug 03 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Buy | P | 4.95 | 604 | 2,988 | 271,504 | 270.9 K to 271.5 K (+0.22 %) |
| Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 15.44 | 1,831 | 28,267 | 141,283 | 143.1 K to 141.3 K (-1.28 %) |
| Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 15.45 | 64 | 989 | 143,114 | 143.2 K to 143.1 K (-0.04 %) |
| Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 15.43 | 303 | 4,676 | 143,178 | 143.5 K to 143.2 K (-0.21 %) |
| Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 15.54 | 337 | 5,238 | 143,481 | 143.8 K to 143.5 K (-0.23 %) |
| Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 15.44 | 716 | 11,055 | 143,818 | 144.5 K to 143.8 K (-0.50 %) |
| Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 15.30 | 4,195 | 64,193 | 144,534 | 148.7 K to 144.5 K (-2.82 %) |
| Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 15.32 | 1,897 | 29,067 | 148,729 | 150.6 K to 148.7 K (-1.26 %) |
| Jun 22 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.30 | 366 | 2,672 | 133,927 | 133.6 K to 133.9 K (+0.27 %) |
| Jun 22 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 7.38 | 366 | 2,700 | 133,561 | 133.9 K to 133.6 K (-0.27 %) |
| May 30 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 16.46 | 6 | 99 | 193,992 | 194 K to 194 K (0.00 %) |
| May 30 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 16.44 | 27 | 444 | 193,986 | 194 K to 194 K (+0.01 %) |
| May 30 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 16.39 | 230 | 3,769 | 193,959 | 193.7 K to 194 K (+0.12 %) |
| May 30 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 16.24 | 282 | 4,581 | 193,729 | 193.4 K to 193.7 K (+0.15 %) |
| May 24 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 16.35 | 136 | 2,224 | 193,447 | 193.3 K to 193.4 K (+0.07 %) |
| May 24 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 16.31 | 30 | 489 | 193,311 | 193.3 K to 193.3 K (+0.02 %) |
| May 24 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 16.40 | 177 | 2,903 | 193,281 | 193.1 K to 193.3 K (+0.09 %) |
| May 24 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 16.67 | 960 | 16,003 | 193,104 | 192.1 K to 193.1 K (+0.50 %) |
| May 22 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 15.50 | 1,803 | 27,947 | 192,144 | 190.3 K to 192.1 K (+0.95 %) |
| May 21 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 15.50 | 1,803 | 27,947 | 192,144 | 190.3 K to 192.1 K (+0.95 %) |
| Jun 13 2007 | IBPI | Ardea Biosciences, ... | Baker Bros. Capital (GP), LLC | 10% Owner | Option Exercise | X | 1.03 | 28,936 | 29,891 | 0 | |
| Jun 13 2007 | IBPI | Ardea Biosciences, ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | X | 1.03 | 28,936 | 29,891 | 133,055 | 104.1 K to 133.1 K (+27.79 %) |
| Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 5.55 | 1,950 | 10,825 | 190,017 | 192 K to 190 K (-1.02 %) |
| Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 5.85 | 3,880 | 22,688 | 191,967 | 195.8 K to 192 K (-1.98 %) |
| Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 5.64 | 16,450 | 92,747 | 195,847 | 212.3 K to 195.8 K (-7.75 %) |
| Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 5.76 | 3,545 | 20,406 | 212,297 | 215.8 K to 212.3 K (-1.64 %) |
| Feb 02 2007 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Bros. Capital (GP), LLC | Director | Sell | J | 0.00 | 14,779 | 0 | 316,360 | 331.1 K to 316.4 K (-4.46 %) |
| Feb 16 2007 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Option Exercise | C | 0.00 | 7,800 | 0 | 46,605 | |
| Feb 16 2007 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Sell | S | 8.72 | 149,930 | 1,307,390 | 4,957 | 154.9 K to 5 K (-96.80 %) |
| Feb 16 2007 | SGEN | SEATTLE GENETICS I ... | Baker Bros. Capital (GP), LLC | Director | Buy | C | 0.00 | 78,000 | 0 | 154,887 | 76.9 K to 154.9 K (+101.45 %) |
| Feb 02 2007 | NRGN | NEUROGEN CORP | Baker Bros. Capital (GP), LLC | Director | Sell | J | 0.00 | 17,987 | 0 | 433,352 | 451.3 K to 433.4 K (-3.99 %) |
| Feb 02 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Option Exercise | J | 11.22 | 28,000 | 314,118 | 315,000 | |
| Feb 02 2007 | INCY | INCYTE CORP | Baker Bros. Capital (GP), LLC | Director | Sell | J | 0.00 | 11,206 | 0 | 270,900 | 282.1 K to 270.9 K (-3.97 %) |
| Mar 13 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 18.28 | 376 | 6,874 | 190,341 | 190 K to 190.3 K (+0.20 %) |
| Mar 05 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 18.02 | 17 | 306 | 189,965 | 189.9 K to 190 K (+0.01 %) |
| Mar 05 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 17.77 | 24 | 426 | 189,948 | 189.9 K to 189.9 K (+0.01 %) |
| Mar 05 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 18.20 | 78 | 1,420 | 189,924 | 189.8 K to 189.9 K (+0.04 %) |
| Feb 21 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 18.54 | 55 | 1,020 | 189,846 | 189.8 K to 189.8 K (+0.03 %) |
| Feb 21 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 18.43 | 1 | 18 | 189,791 | 189.8 K to 189.8 K (0.00 %) |
| Feb 14 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 18.36 | 157 | 2,883 | 189,790 | 189.6 K to 189.8 K (+0.08 %) |
| Feb 14 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 18.26 | 373 | 6,810 | 189,633 | 189.3 K to 189.6 K (+0.20 %) |
| Feb 14 2007 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 17.89 | 49 | 877 | 189,260 | 189.2 K to 189.3 K (+0.03 %) |